Did Our Public Health Institutions Learn Anything From COVID? | Scott Gottlieb, MD
Hold These Truths with Dan Crenshaw
00:00
Do Price Controls Really Hurt Drug Companies?
i want to get your take on h r three, iman. You wrote an ouppit on this recently. I think it's going to hurt the small companies more. Big, big drug companies aren't getting out of the business of developing drugs. They're in it. That's their business model. Ah, they're going to continue to invest in new drugs. But aventure capital firm that invests in clean tech and and media and, you know, internet and byo te,. if the expected returns on the birote investment start to go down because the government's now stepping in to cap those expected returns. And is more regulatory uncertainty. It comes wit the job, right
Transcript
Play full episode
